Skip to main content

Table 2 Satisfaction with the monitoring frequency (n=1905)

From: Satisfaction of well-controlled type 2 diabetes patients with three-monthly and six-monthly monitoring

 

Not satisfied n=171

Satisfied n=1734

 
 

n

Mean ± SD or n (%)

n

Mean ± SD or n (%)

P-value

Age at baseline

171

62.5 ± 8.9

1734

64.6 ± 8.6

0.003

Gender, male

171

111 (64.9%)

1734

1029 (59.3%)

0.156

One or more comorbidities at baseline

171

69 (40.4%)

1734

646 (37.3%)

0.425

Duration of diabetes (in years)

167

5.6 ± 3.3

1695

5.9 ± 3.7

0.283

Current smoker*

165

35 (21.2%)

1672

251 (15.0%)

0.137

SF-36 PCS [scale: 0–100]*

137

44.7 ± 10.4

1414

45.7 ± 10.5

0.027

SF-36 MCS [scale: 0–100]*

137

51.5 ± 10.5

1414

54.1 ± 8.7

0.407

EQ VAS [scale: 0–100]*

155

71.7 ± 13.8

1510

75.2 ± 14.7

0.100

PAID [scale: 0–80]*

152

10.3 ± 11.8

1539

6.5 ± 9.0

<0.001

DTSQ [scale: 0–36]*

158

26.8 ± 6.4

1607

32.4 ± 4.1

<0.001

DTSQ hyper [scale: 0–6]*

166

2.2 ± 1.9

1650

1.3 ± 1.7

<0.001

DTSQ hypo [scale: 0–6]*

166

1.3 ± 1.6

1652

0.8 ± 1.4

0.001

HbA1c (mmol/mol)**

160

49.3 ± 6.8

1656

48.2 ± 7.5

0.077

HDL cholesterol (mmol/l)**

159

1.2 ± 0.3

1637

1.2 ± 0.3

0.089

LDL cholesterol (mmol/l)**

159

2.4 ± 0.8

1634

2.3 ± 0.7

0.044

Total cholesterol (mmol/l)**

159

4.3 ± 0.9

1633

4.2 ± 0.8

0.069

Systolic blood pressure (mmHg)*

130

132.9 ± 15.1

1477

134.0 ± 14.7

0.680

Diastolic blood pressure (mmHg)*

130

78.1 ± 9.9

1474

76.3 ± 9.2

0.025

BMI (kg/m2)*

120

29.1 ± 4.2

1373

29.1 ± 4.8

0.609

  1. * Final measurement, corrected for baseline measurement.
  2. ** Last known measurement during follow-up.
  3. SF-36 Short-Form 36, PCS Physical Component Score, MCS Mental Component Score, EQ VAS EuroQol Visual Analogue Scale, PAID Problem Areas In Diabetes, DTSQ Diabetes Treatment Satisfaction Questionnaire status.